Go to
JCI Insight
Citations to this article
Abstract
Cutaneous T cell lymphomas (CTCLs) are a heterogenous group of lymphoproliferative disorders caused by clonally derived, skin-invasive T cells. Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common types of CTCLs and are characterized by malignant CD4+/CLA+/CCR4+ T cells that also lack the usual T cell surface markers CD7 and/or CD26. As MF/SS advances, the clonal dominance of the malignant cells results in the expression of predominantly Th2 cytokines, progressive immune dysregulation in patients, and further tumor cell growth. This review summarizes recent insights into the pathogenesis and immunobiology of MF/SS and how these have shaped current therapeutic approaches, in particular the growing emphasis on enhancement of host antitumor immune responses as the key to successful therapy.
Authors
Ellen J. Kim, Stephen Hess, Stephen K. Richardson, Sara Newton, Louise C. Showe, Bernice M. Benoit, Ravi Ubriani, Carmela C. Vittorio, Jacqueline M. Junkins-Hopkins, Maria Wysocka, Alain H. Rook
Total citations by year
Citation information
Citations to this article (320)
| Title and authors | Publication | Year |
|---|---|---|
|
The Role of Killer Ig-like Receptors in Diseases from A to Z
Agnello L, Masucci A, Tamburello M, Vassallo R, Massa D, Giglio RV, Midiri M, Gambino CM, Ciaccio M |
International Journal of Molecular Sciences | 2025 |
|
A rare case of mycosis fungoides with porokeratosis-like lesions: a case report and review of previous literature
Alkeraye SS, Alsehli TN, Alhumidi A, Al-Husain K, Nagshabandi KN |
AME Case Reports | 2025 |
|
Memory T-Cell Phenotype in Cutaneous T-Cell Lymphoma Is Modified by Germline Gene Gametocyte Specific Factor 1.
Martínez Villarreal A, Gantchev J, Xie P, Lefrançois P, Ramchatesingh B, Litvinov IV |
Experimental dermatology | 2025 |
|
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy.
Ren J, Liao X, Lewis JM, Chang J, Qu R, Carlson KR, Foss F, Girardi M |
Nature Communications | 2024 |
|
Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment.
Nguyen WQ, Chrisman LP, Enriquez GL, Hooper MJ, Griffin TL, Ahmad M, Rahman S, Green SJ, Seed PC, Guitart J, Burns MB, Zhou XA |
Frontiers in immunology | 2024 |
|
Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma.
Mazzetto R, Miceli P, Tartaglia J, Ciolfi C, Sernicola A, Alaibac M |
2024 | |
|
Vitamin D in Cutaneous T-Cell Lymphoma.
Ødum AF, Geisler C |
Cells | 2024 |
|
Reverse causation bias: A simulation study comparing first- and second-line treatments with an overlap of symptoms between treatment indication and studied outcome
Øland CB, Ranch LS, Skaaby T, Delvin T, Jakobsen HB, Pipper CB |
PloS one | 2024 |
|
Skin-directed therapy and biologic response modifiers in mycosis fungoides
Grandi V, Colantuono VA, Pimpinelli N |
Dermatology Reports | 2024 |
|
CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma
Luo CH, Hu LH, Liu JY, Xia L, Zhou L, Sun RH, Lin CC, Qiu X, Jiang B, Yang MY, Zhang XH, Yang XB, Chen GQ, Lu Y |
Nature Communications | 2024 |
|
Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma.
Boh E, Kuraitis D, Jacobson A, Sikes M |
Dermatology and Therapy | 2023 |
|
Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management.
Miyashiro D, Sanches JA |
Frontiers in Oncology | 2023 |
|
The link between psoriasis and other diseases based on epidemiological and genetic analyses.
Adamski Z, Kanabaj K, Kuźniak A |
2023 | |
|
Extranodal lymphoma: pathogenesis, diagnosis and treatment.
Yang H, Xun Y, Ke C, Tateishi K, You H |
2023 | |
|
What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S, Roggo A, Pawlik L, Dummer R, Ramelyte E |
Current Oncology Reports | 2023 |
|
Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sézary Syndrome.
Abreu Rocha C, Drummond Borges M, Santos GM, Sousa M, Teixeira T |
Cureus | 2023 |
|
Immunosequencing applications in cutaneous T-cell lymphoma.
Mandel J, Gleason L, Joffe D, Bhatti S, Nikbakht N |
Frontiers in immunology | 2023 |
|
Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides.
Yu Z, Vieyra-Garcia P, Benezeder T, Crouch JD, Kim IR, O'Malley JT, Devlin PM, Gehad A, Zhan Q, Gudjonsson JE, Sarkar MK, Kahlenberg JM, Gerard N, Teague JE, Kupper TS, LeBoeuf NR, Larocca C, Tawa M, Pomahac B, Talbot SG, Orgill DP, Wolf P, Clark RA |
Journal of Investigative Dermatology | 2023 |
|
Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
Atallah-Yunes SA, Robertson MJ |
Frontiers in immunology | 2022 |
|
T Cell Extracellular Traps: Tipping the Balance Between Skin Health and Disease.
Ouyang K, Oparaugo N, Nelson AM, Agak GW |
Frontiers in immunology | 2022 |
|
Partial remission of advanced untreated Sézary syndrome after COVID-19.
Snowden C, Ng S, Choi J |
JAAD Case Reports | 2022 |
|
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data.
Querfeld C, Scarisbrick JJ, Assaf C, Kim YH, Guitart J, Quaglino P, Hodak E |
American Journal of Clinical Dermatology | 2022 |
|
MicroRNAs and their signaling pathway in mycosis fungoides.
Sun Z, Yao X, Ding X, Li X, Tian X |
Medicine | 2022 |
|
Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings.
Wehkamp U, Ardigò M, Papadavid E, Querfeld C, Nikbakht N |
Advances in Therapy | 2022 |
|
Ultrasound-guided microwave ablation as a palliative treatment for mycosis fungoides eyelid involvement: A case report.
Chen YW, Yang HZ, Zhao SS, Zhang Z, Chen ZM, Feng HH, An MH, Wang KK, Duan R, Chen BD |
World journal of clinical cases | 2022 |
|
Factors Associated With In-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable Analysis.
King ALO, Lee V, Mirza FN, Jairam V, Yang DX, Yu JB, Park HS, Girardi M, Wilson LD, An Y |
Cureus | 2022 |
|
The Skin Microbiome in Cutaneous T-Cell Lymphomas (CTCL)-A Narrative Review.
Łyko M, Jankowska-Konsur A |
2022 | |
|
Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas.
Caruso L, Castellino A, Dessì D, Flenghi L, Giordano A, Ibatici A, Massone C, Pileri A, Proietti I, Pupo L, Quaglino P, Rupoli S, Zinzani PL |
Cancer management and research | 2022 |
|
Therapeutic Antibodies in Cancer Treatment in the UK.
Eltarhoni K, Kamel F, Ihebunezie K, Nisar P, Soloviev M |
International journal of molecular sciences | 2022 |
|
Advances in the understanding and treatment of Cutaneous T-cell Lymphoma.
Bakr FS, Whittaker SJ |
Frontiers in Oncology | 2022 |
|
Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia.
Allen PB, Goyal S, Switchenko J, Tarabadkar E, Pouch S, Parikh P, Palmer A, Martini D, Kim E, Lechowicz MJ |
Leukemia & Lymphoma | 2022 |
|
Skin Tape Strip Proteomics in Mycosis Fungoides Identifies Tumor-Associated Biomarkers.
Techner JM, Hooper MJ, Evans S, LeWitt TM, Paller AS, Guitart J, Lu KQ, Zhou XA |
Journal of Investigative Dermatology | 2022 |
|
JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)
CK Vadivel, M Gluud, S Torres-Rusillo, L Boding, A Willerslev-Olsen, TB Buus, TK Nielsen, JL Persson, CM Bonefeld, C Geisler, T Krejsgaard, AT Fuglsang, N Odum, A Woetmann |
Cancers | 2021 |
|
CCR4 as a Therapeutic Target for Cancer Immunotherapy
O Yoshie |
Cancers | 2021 |
|
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication
JS Durgin, DM Weiner, M Wysocka, AH Rook |
Journal of the American Academy of Dermatology | 2021 |
|
The Peripheral T‐Cell Lymphomas
OA O'Connor, WS Kim, PL Zinzani |
2021 | |
|
The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
A Pileri, A Guglielmo, V Grandi, SA Violetti, D Fanoni, P Fava, C Agostinelli, E Berti, P Quaglino, N Pimpinelli |
Cells | 2021 |
|
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver
JP Nicolay, JD Albrecht, S AlbertiVioletti, E Berti |
European Journal of Immunology | 2021 |
|
PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development And Progression
N García-Díaz, B Casar, R Alonso-Alonso, L Quevedo, M Rodríguez, F Ruso-Julve, A Esteve-Codina, M Gut, AA Gru, MC González-Vela, I Gut, JL Rodriguez-Peralto, I Varela, PL Ortiz-Romero, MA Piris, JP Vaqué |
Journal of Investigative Dermatology | 2021 |
|
Sézary Syndrome: a clinico-pathological study of 9 cases
V BOLCATO, S BARRUSCOTTI, AD SILVESTRI, CF TOMASINI, V BRAZZELLI |
Italian journal of dermatology and venereology | 2021 |
|
Screening for second malignancies in mycosis fungoides: non‐Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma
A Goyal, D OLeary, K Goyal, N Rubin, M Janakiram |
Journal of the European Academy of Dermatology and Venereology | 2021 |
|
Combination therapies for mycosis fungoides/Sézary syndrome: biologic rationale and recommendations
DJ Lewis, AH Rook |
International Journal of Dermatology | 2021 |
|
Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort
D Miyashiro, JA Sanches |
International Journal of Dermatology | 2021 |
|
Tratamiento de la micosis fungoide con fototerapia
JO Parra, LP Cardona, MC Mesa |
Piel | 2021 |
|
Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma
A Willerslev-Olsen, LM Gjerdrum, LM Lindahl, TB Buus, EM Pallesen, M Gluud, M Bzorek, BS Nielsen, MR Kamstrup, AH Rittig, CM Bonefeld, T Krejsgaard, C Geisler, SB Koralov, T Litman, JC Becker, A Woetmann, L Iversen, N Odum |
Journal of Investigative Dermatology | 2021 |
|
Treatment of lymphocyte‐variant hypereosinophilic syndrome (L‐HES): what to consider after confirming the elusive diagnosis
AK Williams, C Dou, LY Chen |
British Journal of Haematology | 2021 |
|
Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma
M Lin, CM Kowolik, J Xie, S Yadav, LE Overman, DA Horne |
Cancers | 2021 |
|
Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures
A Herrera, A Cheng, EP Mimitou, A Seffens, D George, M Bar-Natan, A Heguy, KV Ruggles, JU Scher, K Hymes, JA Latkowski, N Ødum, ME Kadin, Z Ouyang, LJ Geskin, P Smibert, TB Buus, SB Koralov |
Blood | 2021 |
|
Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma
SJ Mehdi, A Moerman-Herzog, HK Wong |
BMC Cancer | 2021 |
|
Patterns of Gene Expression in Cutaneous T-Cell Lymphoma: Systematic Review of Transcriptomic Studies in Mycosis Fungoides
M Motamedi, MZ Xiao, A Iyer, R Gniadecki |
Cells | 2021 |
|
NLRP3 Regulates IL-4 Expression in TOX+ CD4+ T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression
E Huanosta-Murillo, M Alcántara-Hernández, B Hernández-Rico, G Victoria-Acosta, P Miranda-Cruz, MA Domínguez-Gómez, F Jurado-Santacruz, G Patiño-López, V Pérez-Koldenkova, A Palma-Guzmán, P Licona-Limón, EM Fuentes-Pananá, A Lemini-López, LC Bonifaz |
Frontiers in immunology | 2021 |
|
What factors guide treatment selection in mycosis fungoides and Sezary syndrome?
Kim YH |
Hematology | 2021 |
|
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
M Gluud, A Willerslev-Olsen, LM Gjerdrum, LM Lindahl, TB Buus, MH Andersen, CM Bonefeld, T Krejsgaard, IV Litvinov, L Iversen, JC Becker, JL Persson, SB Koralov, T Litman, C Geisler, A Woetmann, N Odum |
Cancers | 2020 |
|
Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma
AM Gaydosik, DS Queen, MH Trager, OE Akilov, LJ Geskin, P Fuschiotti |
Blood | 2020 |
|
How It Works
Z Yu, P Wolf |
Dermatologic Clinics | 2020 |
|
Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma
V Stolearenco, MR Namini, SS Hasselager, M Gluud, TB Buus, A Willerslev-Olsen, N Ødum, T Krejsgaard |
Frontiers in Cell and Developmental Biology | 2020 |
|
Determining the role of allergic contact dermatitis in mycosis fungoides
M O'Donnell, D Shalabi, AA Gaspari, N Nikbakht |
International Journal of Dermatology | 2020 |
|
Progression of mycosis fungoides after treatment with dupilumab: A case report
D Miyashiro, AG Vivarelli, F Gonçalves, J CuryMartins, JA Sanches |
Dermatologic Therapy | 2020 |
|
Frequent and Persistent PLCG1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT Signaling
VM Patel, CE Flanagan, M Martins, CL Jones, RM Butler, WJ Woollard, FS Bakr, A Yoxall, N Begum, M Katan, SJ Whittaker, TJ Mitchell |
Journal of Investigative Dermatology | 2020 |
|
Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: A systematic review and meta-analysis
A Goyal, D O'Leary, K Goyal, K Patel, D Pearson, M Janakiram |
Journal of the American Academy of Dermatology | 2020 |
|
Mogamulizumab in the treatment of advanced mycosis fungoides and Sézary syndrome: safety and efficacy
DJ Lewis, AH Rook |
Expert Review of Anticancer Therapy | 2020 |
|
Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients
AM Villarreal, J Gantchev, F Lagacé, A Barolet, D Sasseville, N Ødum, YV Charli-Joseph, AH Salazar, IV Litvinov |
Cancers | 2020 |
|
Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center
D Miyashiro, JA Sanches |
Scientific Reports | 2020 |
|
Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis
A Goyal, D O'Leary, K Goyal, N Rubin, K Bohjanen, M Hordinsky, ST Chen, G Pongas, LM Duncan, A Lazaryan |
Journal of the American Academy of Dermatology | 2020 |
|
Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome
A Willerslev-Olsen, TB Buus, C Nastasi, E Blümel, M Gluud, CM Bonefeld, C Geisler, LM Lindahl, M Vermeer, MA Wasik, L Iversen, JC Becker, MH Andersen, LM Gjerdrum, IV Litvinov, T Litman, T Krejsgaard, A Woetmann, N Ødum |
Blood Cancer Journal | 2020 |
|
Photochemotherapy Induces Interferon Type III Expression via STING Pathway
E Biskup, BD Larsen, L Rib, L Folkersen, O Niazi, MR Kamstrup, CS Sørensen |
Cells | 2020 |
|
Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)
PB Allen, J Switchenko, A Ayers, E Kim, MJ Lechowicz |
Leukemia & Lymphoma | 2020 |
|
Cost of early-stage mycosis fungoides treatments in Spain PL Ortiz-Romero, O Servitje, MT Estrach, RM Izu-Belloso, R Fernández-de-Misa, F Gallardo, N López-Martínez, A Pérez-Mitru |
ClinicoEconomics and Outcomes Research: CEOR | 2020 |
|
MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells
M Gluud, S Fredholm, E Blümel, A Willerslev-Olsen, TB Buus, C Nastasi, T Krejsgaard, CM Bonefeld, A Woetmann, L Iversen, T Litman, C Geisler, N Ødum, LM Lindahl |
Dermatology | 2020 |
|
Increased Expression of Delta-like Ligand 4 in Mycosis Fungoides.
Boki H, Miyagaki T, Shono Y, Kamijo H, Oka T, Suga H, Asano Y, Sugaya M, Sato S |
Acta Dermato Venereologica | 2020 |
|
Mycosis Fungoides and Sézary Syndrome
C Larocca, T Kupper |
Hematology/Oncology Clinics of North America | 2019 |
|
Skin Directed Therapy in Cutaneous T-Cell Lymphoma
ES Tarabadkar, MM Shinohara |
Frontiers in Oncology | 2019 |
|
Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing
A Iyer, D Hennessey, S OKeefe, J Patterson, W Wang, T Salopek, GK Wong, R Gniadecki |
Blood Advances | 2019 |
|
Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance
RM Butler, RC McKenzie, CL Jones, CE Flanagan, WJ Woollard, M Demontis, S Ferreira, I Tosi, S John, SJ Whittaker, TJ Mitchell |
Journal of Investigative Dermatology | 2019 |
|
A Case of Histiocytic Sarcoma Arising from Mycosis Fungoides
EA Burns, C Gentille, S Kasparian, SR Pingali |
Case Reports in Hematology | 2019 |
|
Radiation therapy in mycosis fungoid patient
M Chellakhi, I Khalfaoui, N Benchakroun, Z Bouchbika, H Jouhadi, N Tawfiq, S Sahraoui, A Benider, N Chellakhi, A Quessar |
The Pan African medical journal | 2019 |
|
Early changes in gene expression of the entire pathological process in Cutaneous T‐cell lymphoma
Y Li, X Wang, Y Li, R Ma, Z Zhao, J Ren, J Men |
Journal of Cellular Biochemistry | 2019 |
|
IL ‐10–producing regulatory B cells in skin diseases
H Suga, S Sato |
2019 | |
|
αEβ7 Expression Increases With the Extent of Cutaneous Involvement in Mycosis Fungoides
MC Barata, SP Teixeira, MD Batista, J Tomimori, G Landman, MR Silva |
The American Journal of Dermatopathology | 2019 |
|
Current status of histone deacetylase inhibitors in cutaneous T-cell lymphoma
MH Trager, LJ Geskin |
Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia | 2019 |
|
Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments
A Sivanand, P Surmanowicz, R Alhusayen, P Hull, IV Litvinov, Y Zhou, R Gniadecki |
Journal of Cutaneous Medicine & Surgery | 2019 |
|
The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T‐cell lymphoma
M Yamaguchi, S Morizane, T Hamada, T Miyake, M Sugaya, H Iwata, K Fujii, R HaramotoShiratsuki, Y Nakagawa, M Miura, K Ohshima, K Morishita, T Takahashi, M Imada, K Okada, J Uehara, J SowaOsako, K Iwatsuki |
The Journal of Dermatology | 2019 |
|
Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma
B Mundy-Bosse, N Denlinger, E McLaughlin, N Chakravarti, S Hwang, L Chen, HC Mao, D Kline, Y Youssef, R Kohnken, DA Lee, G Lozanski, AG Freud, P Porcu, B William, MA Caligiuri, A Mishra |
Blood Advances | 2018 |
|
PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21
Y Wang, X Gu, W Li, Q Zhang, C Zhang |
Journal of Dermatological Science | 2018 |
|
The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
IG de los Fayos Alonso, HC Liang, S Turner, S Lagger, O Merkel, L Kenner |
Cancers | 2018 |
|
Serum metabolite profiling of cutaneous T-cell lymphoma based on a multiplatform approach
G Jiang, X Shen, H Kang, K Li, J Zheng, Y Yu |
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 2018 |
|
SATB1 in Malignant T Cells
S Fredholm, A Willerslev-Olsen, Ö Met, L Kubat, M Gluud, SL Mathiasen, C Friese, E Blümel, DL Petersen, T Hu, C Nastasi, LM Lindahl, TB Buus, T Krejsgaard, MA Wasik, KL Kopp, SB Koralov, JL Persson, CM Bonefeld, C Geisler, A Woetmann, L Iversen, JC Becker, N Ødum |
Journal of Investigative Dermatology | 2018 |
|
IL-31: A new key player in dermatology and beyond
IS Bağci, T Ruzicka |
Journal of Allergy and Clinical Immunology | 2018 |
|
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
SR Kim, JM Lewis, BM Cyrenne, PF Monico, FN Mirza, KR Carlson, FM Foss, M Girardi |
Oncotarget | 2018 |
|
Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
H Torrey, M Khodadoust, L Tran, D Baum, A Defusco, YH Kim, DL Faustman |
Leukemia | 2018 |
|
Pigmented Ethnic Skin and Imported Dermatoses: A Text-Atlas
CE Orfanos, CC Zouboulis, C Assaf |
2018 | |
|
Specific TCR gene rearrangements in mycosis fungoides: does advanced clinical stage show a preference?
E Marks, Y Wang, Y Shi, J Susa, M Jacobson, DY Goldstein |
Journal of clinical pathology | 2018 |
|
A Practical Guide to Skin Cancer
A Hanlon |
2018 | |
|
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma
L Qiu, F Liu, S Yi, X Li, X Liu, C Xiao, CG Lian, P Tu, Y Wang |
Journal of Investigative Dermatology | 2018 |
|
TIGIT and Helios Are Highly Expressed on CD4+ T Cells in Sézary Syndrome Patients
N Jariwala, B Benoit, AV Kossenkov, LK Oetjen, TM Whelan, CM Cornejo, J Takeshita, BS Kim, LC Showe, M Wysocka, AH Rook |
Journal of Investigative Dermatology | 2017 |
|
Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome
LJ Geskin, OE Akilov, S Kwon, M Schowalter, S Watkins, TL Whiteside, LH Butterfield, LD Falo |
Cancer Immunology, Immunotherapy | 2017 |
|
Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome
KC Manfrere, MP Torrealba, DR Miyashiro, NZ Pereira, FS Yoshikawa, M Oliveira, J Cury-Martins, AJ Duarte, JA Sanches, MN Sato |
Oncotarget | 2017 |
|
Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome
S Berg, J Villasenor-Park, P Haun, EJ Kim |
Current Hematologic Malignancy Reports | 2017 |
|
Psoralen with ultraviolet A-induced apoptosis of cutaneous lymphoma cell lines is augmented by type I interferons via the JAK1-STAT1 pathway
W Liszewski, DG Naym, E Biskup, R Gniadecki |
Photodermatology, Photoimmunology & Photomedicine | 2017 |
|
Clinical and Basic Immunodermatology
AA Gaspari, SK Tyring, DH Kaplan |
Clinical and Basic Immunodermatology | 2017 |
|
Chlormethine 160 mcg/g gel in mycosis fungoides-type cutaneous T-cell lymphoma: a profile of its use in the EU
LJ Scott |
Drugs & Therapy Perspectives | 2017 |
|
Forodesine in the treatment of cutaneous T-cell lymphoma
DJ Lewis, M Duvic |
Expert Opinion on Investigational Drugs | 2017 |
|
The discovery and development of romidepsin for the treatment of T-cell lymphoma
P Smolewski, T Robak |
Expert Opinion on Drug Discovery | 2017 |
|
Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach
Anupam Das, Saumya Panda |
Indian journal of dermatology | 2017 |
|
Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox
DJ Lewis, H Dao, P Nagarajan, M Duvic |
JAAD Case Reports | 2017 |
|
Vorinostat and Mithramycin A in combination therapy as an interesting strategy for the treatment of Sézary T lymphoma: a transcriptomic approach
R Ragheb, G Venton, R Chelbi, N Bonnet, TL Treut, V Ivanov, C Mercier, P Poulin, N Beaufils, J Gabert, P Suchon, P Rihet, B Loriod, B Kahn-Perlès, RT Costello |
Archives of Dermatological Research | 2017 |
|
Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series
DJ Lewis, YA Byekova, DA Emge, M Duvic |
Journal of Dermatological Treatment | 2017 |
|
Vitamin D and the Skin: An Update for Dermatologists
E Kechichian, K Ezzedine |
American Journal of Clinical Dermatology | 2017 |
|
Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy
M Duvic, SE Bates, R Piekarz, R Eisch, YH Kim, A Lerner, T Robak, A Samtsov, JC Becker, W McCulloch, J Waksman, S Whittaker |
Leukemia & Lymphoma | 2017 |
|
A Treatise on Topical Corticosteroids in Dermatology
K Lahiri |
A Treatise on Topical Corticosteroids in Dermatology | 2017 |
|
Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach
Anupam Das, Saumya Panda |
Indian journal of dermatology | 2017 |
|
Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides
M Mascolo, MF Romano, G Ilardi, S Romano, A Baldo, M Scalvenzi, G Argenziano, F Merolla, D Russo, S Varricchio, F Pagliuca, M Russo, G Ciancia, GD Rosa, S Staibano |
Journal of the European Academy of Dermatology and Venereology | 2017 |
|
Classification and recommended treatment options for folliculotropic mycosis fungoides
S Santen, MH Vermeer, R Willemze |
Expert Opinion on Orphan Drugs | 2017 |
|
Biologic and Systemic Agents in Dermatology
PS Yamauchi |
Biologic and Systemic Agents in Dermatology | 2017 |
|
Role of dysregulated cytokine signaling and bacterial triggers in the pathogenesis of Cutaneous T Cell Lymphoma
MH Fanok, A Sun, LK Fogli, V Narendran, M Eckstein, K Kannan, I Dolgalev, C Lazaris, A Heguy, ME Laird, MS Sundrud, C Liu, J Kutok, RS Lacruz, JA Latkowski, I Aifantis, N Ødum, KB Hymes, S Goel, SB Koralov |
Journal of Investigative Dermatology | 2017 |
|
ITK inhibition for the targeted treatment of CTCL
I Bustos-Villalobos, JW Bergstrom, NE Haigh, JI Luna, A Mitra, AI Marusina, AA Merleev, EA Wang, A Sukhov, H Sultani, R Liu, G Bhardwaj, W Guo, HJ Kung, KS Lam, E Maverakis |
Journal of Dermatological Science | 2017 |
|
Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome
J Janiga, J Kentley, C Nabhan, F Abdulla |
Leukemia & Lymphoma | 2017 |
|
Neoplastic Diseases of the Blood
PH Wiernik, JP Dutcher, MA Gertz |
2017 | |
|
Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction
JF Gibson, J Huang, KJ Liu, KR Carlson, F Foss, J Choi, R Edelson, JW Hussong, R Mohl, S Hill, M Girardi |
Journal of the American Academy of Dermatology | 2016 |
|
Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside
WE Damsky, J Choi |
Current Treatment Options in Oncology | 2016 |
|
STAT Assays with a TWIST: Differentiating Sézary Syndrome from Erythrodermic Inflammatory Dermatitis
HK Wong |
Journal of Investigative Dermatology | 2016 |
|
Mac attack: macrophages as key drivers of cutaneous T-cell lymphoma pathogenesis
C Assaf, ST Hwang |
Experimental Dermatology | 2016 |
|
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
I Saulite, W Hoetzenecker, S Weidinger, A Cozzio, E Guenova, U Wehkamp |
BioMed Research International | 2016 |
|
Gelling Your Dermatology Nursing Practice: A Practical Guide for Managing the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel
SA McCann, AB Chase, MC Tawa |
Journal of the Dermatology Nurses' Association | 2016 |
|
Serum Vitamin D and Vitamin D Receptor Gene Polymorphism in Mycosis Fungoides Patients: A Case Control Study
H Rasheed, RA Hegazy, HI Gawdat, DA Mehaney, MM Kamel, MM Fawzy, MM Nooh, HA Darwish, M Zmijewski |
PloS one | 2016 |
|
SpringerBriefs in Immunology
W Lasek, R Zagozdzon |
SpringerBriefs in Immunology | 2016 |
|
The Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin
BH Kaffenberger, MA Bechtel, P Porcu |
The Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin | 2016 |
|
A Novel Xenogeneic Graft-Versus-Host Disease Model for Investigating the Pathological Role of Human CD4 + or CD8 + T Cells Using Immunodeficient NOG Mice
R Ito, I Katano, K Kawai, M Yagoto, T Takahashi, Y Ka, T Ogura, R Takahashi, M Ito |
American Journal of Transplantation | 2016 |
|
Clinician's Guide to Mycosis Fungoides
PK Beigi |
Clinician's Guide to Mycosis Fungoides | 2016 |
|
Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping
HH Kagdi, MA Demontis, PA Fields, JC Ramos, CR Bangham, GP Taylor |
Cancer Medicine | 2016 |
|
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
T Krejsgaard, LM Lindahl, NP Mongan, MA Wasik, IV Litvinov, L Iversen, E Langhoff, A Woetmann, N Odum |
Seminars in Immunopathology | 2016 |
|
CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214
BM Benoit, N Jariwala, G OConnor, LK Oetjen, TM Whelan, A Werth, AB Troxel, H Sicard, L Zhu, C Miller, J Takeshita, DW McVicar, BS Kim, AH Rook, M Wysocka |
Archives of Dermatological Research | 2016 |
|
Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome
KC Manfrere, MP Torrealba, DR Miyashiro, LM Oliveira, GC de Carvalho, JF Lima, AC Branco, NZ Pereira, J Pereira, JA Sanches, MN Sato |
Oncotarget | 2016 |
|
Correlation between mycosis fungoides and pregnancy
FF Naeini, B Abtahi-naeini, J Najafian, A Saffaei, M Pourazizi |
Saudi Medical Journal | 2016 |
|
Immunology of the Skin
K Kabashima |
2016 | |
|
Bortezomib Inhibits Expression of TGF- 1, IL-10, and CXCR4, Resulting in Decreased Survival and Migration of Cutaneous T Cell Lymphoma Cells
TP Chang, V Poltoratsky, I Vancurova |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
|
Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
LJ Geskin, S Viragova, DB Stolz, P Fuschiotti |
Blood | 2015 |
|
Cutaneous T-Cell Lymphoma: The Yin and Yang of Inflammation and Neoplasia
X Wu, ST Hwang |
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research | 2015 |
|
Genomic landscape of cutaneous T cell lymphoma
J Choi, G Goh, T Walradt, BS Hong, CG Bunick, K Chen, RD Bjornson, Y Maman, T Wang, J Tordoff, K Carlson, JD Overton, KJ Liu, JM Lewis, L Devine, L Barbarotta, FM Foss, A Subtil, EC Vonderheid, RL Edelson, DG Schatz, TJ Boggon, M Girardi, RP Lifton |
Nature Genetics | 2015 |
|
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
AH Rook, JC Gelfand, M Wysocka, AB Troxel, B Benoit, C Surber, R Elenitsas, MA Buchanan, DS Leahy, R Watanabe, IR Kirsch, EJ Kim, RA Clark |
Blood | 2015 |
|
A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies
H Sicard, C Bonnafous, A Morel, M Bagot, A Bensussan, A Marie-Cardine |
OncoImmunology | 2015 |
|
The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma
AO Huen, EJ Kim |
Dermatologic Clinics | 2015 |
|
The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma
N Spaccarelli, AH Rook |
Dermatologic Clinics | 2015 |
|
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes
L Wang, X Ni, KR Covington, BY Yang, J Shiu, X Zhang, L Xi, Q Meng, T Langridge, J Drummond, LA Donehower, H Doddapaneni, DM Muzny, RA Gibbs, DA Wheeler, M Duvic |
Nature Genetics | 2015 |
|
Primary cutaneous lymphomas: diagnosis and treatment
M Sokołowska-Wojdyło, K Olek-Hrab, K Ruckemann-Dziurdzińska |
POSTEP DERM ALERGOL | 2015 |
|
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma
Y Huang, MW Su, X Jiang, Y Zhou |
Blood | 2014 |
|
Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications
G Inghirami, WC Chan, S Pileri |
Immunological Reviews | 2014 |
|
TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial
B Dreno, M Urosevic-Maiwald, Y Kim, J Guitart, M Duvic, O Dereure, A Khammari, AC Knol, A Derbij, M Lusky, I Didillon, AM Santoni, B Acres, V Bataille, MP Chenard, P Bleuzen, JM Limacher, R Dummer |
PloS one | 2014 |
|
Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma
TP Chang, I Vancurova |
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 2014 |
|
The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications
E Mazzeo, L Rubino, M Buglione, P Antognoni, SM Magrini, F Bertoni, M Parmiggiani, P Barbieri, F Bertoni |
Reports of Practical Oncology & Radiotherapy | 2014 |
|
Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation
T Krejsgaard, A Willerslev-Olsen, LM Lindahl, CM Bonefeld, SB Koralov, C Geisler, MA Wasik, R Gniadecki, M Kilian, L Iversen, A Woetmann, N Odum |
Blood | 2014 |
|
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
JJ Scarisbrick, YH Kim, SJ Whittaker, GS Wood, MH Vermeer, HM Prince, P Quaglino |
The British journal of dermatology | 2014 |
|
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
E Guenova, W Hoetzenecker, S Rozati, MP Levesque, R Dummer, A Cozzio |
Expert Opinion on Investigational Drugs | 2014 |
|
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
J Sahu, M Sepassi, M Nagao, YH Kim |
Clinical Investigation | 2014 |
|
Vitamin D deficiency in mycosis fungoides and Sézary syndrome patients is similar to other cancer patients
R Talpur, KM Cox, M Hu, ER Geddes, MK Parker, BY Yang, PA Armstrong, P Liu, M Duvic |
Clinical Lymphoma Myeloma and Leukemia | 2014 |
|
CCR4 + T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16
M Tuzova, J Richmond, D Wolpowitz, C Curiel-Lewandrowski, K Chaney, T Kupper, W Cruikshank |
Leukemia & Lymphoma | 2014 |
|
CCR4 and its ligands: from bench to bedside
O Yoshie, K Matsushima |
International Immunology | 2014 |
|
Necrobiotic features in both cutaneous and lymph node lesions in a patient with interstitial mycosis fungoides
T Hamada, K Tada, Y Aoyama, K Iwatsuki |
International Journal of Dermatology | 2014 |
|
Targeted therapies for cutaneous T-cell lymphomas
JB Kaplan, J Guitart, FJ Giles |
Expert Review of Hematology | 2014 |
|
FoxP3-Positive T-Regulatory Cells in Lymph Nodes with Mycosis Fungoides and Sézary Syndrome
R Bhat, B Khandpur, EC Vonderheid, JS Hou |
Lymphoma | 2014 |
|
TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial
B Dreno, M Urosevic-Maiwald, Y Kim, J Guitart, M Duvic, O Dereure, A Khammari, AC Knol, A Derbij, M Lusky, I Didillon, AM Santoni, B Acres, V Bataille, MP Chenard, P Bleuzen, JM Limacher, R Dummer, JW Glod |
PloS one | 2014 |
|
Cutaneous Hematopathology
HD Cualing, ME Kadin, MP Hoang, MB Morgan |
2014 | |
|
NEW AND EMERGING HDAC INHIBITORS FOR THE TREATMENT OF DISEASES
SS Mahajan, A Chavan |
2014 | |
|
Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
A Willerslev-Olsen, T Krejsgaard, L Lindahl, C Bonefeld, M Wasik, S Koralov, C Geisler, M Kilian, L Iversen, A Woetmann, N Odum |
Toxins | 2013 |
|
Advances in Veterinary Dermatology: Torres/Advances
J Bexley, TJ Nuttall, B Hammerberg, JR Fitzgerald, RE Halliwell |
Advances in Veterinary Dermatology: Torres/Advances | 2013 |
|
Toll-like receptors in lymphoid malignancies: Double-edged sword
S Harsini, M Beigy, M Akhavan-Sabbagh, N Rezaei |
Critical Reviews in Oncology/Hematology | 2013 |
|
CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients
M Wysocka, AV Kossenkov, BM Benoit, AB Troxel, E Singer, A Schaffer, B Kim, T Dentchev, S Nagata, T Ise, LC Showe, AH Rook |
Journal of Investigative Dermatology | 2013 |
|
NFκB function and regulation in cutaneous T-cell lymphoma
TP Chang, I Vancurova |
American journal of cancer research | 2013 |
|
Loss of melanocytes in hypopigmented mycosis fungoides: a study of 18 patients: Loss of melanocytes in MF
FC Furlan, BA de Pereira, LF da Silva, JA Sanches |
Journal of Cutaneous Pathology | 2013 |
|
Advances in the management of skin cancer: Management of skin cancer
PD Martin, DJ Argyle |
Veterinary Dermatology | 2013 |
|
The antihistamines clemastine and desloratadine inhibit STAT3 and c-Myc activities and induce apoptosis in cutaneous T-cell lymphoma cell lines
U Döbbeling, Y Waeckerle-Men, F Zabel, N Graf, TM Kündig, P Johansen |
Experimental Dermatology | 2013 |
|
Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology*
FC Furlan, JA Sanches |
Anais Brasileiros de Dermatologia | 2013 |
|
Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology
FC Furlan, JA Sanches |
Anais Brasileiros de Dermatologia | 2013 |
|
Lymphoma
A Younes, B Coiffier |
Lymphoma | 2013 |
|
Les lymphomes cutanés
M Bagot |
2013 | |
|
T H 2 Cytokines from Malignant Cells Suppress T H 1 Responses and Enforce a Global T H 2 Bias in Leukemic Cutaneous T-cell Lymphoma
E Guenova, R Watanabe, JE Teague, JA Desimone, Y Jiang, M Dowlatshahi, C Schlapbach, K Schaekel, AH Rook, M Tawa, DC Fisher, TS Kupper, RA Clark |
Clinical cancer research | 2013 |
|
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
YH Kim, D Gratzinger, C Harrison, JD Brody, DK Czerwinski, WZ Ai, A Morales, F Abdulla, L Xing, D Navi, RJ Tibshirani, RH Advani, B Lingala, S Shah, RT Hoppe, R Levy |
Blood | 2012 |
|
Tissue-Specific Homing of Immune Cells in Malignant Skin Tumors
H Jókai, M Marschalkó, J Csomor, J Szakonyi, O Kontár, G Barna, S Kárpáti, P Holló |
Pathology & Oncology Research | 2012 |
|
8-Methoxypsoralen plus UVA treatment increases the proportion of CLA+ CD25+ CD4+ T cells in lymph nodes of K5.hTGFβ1 transgenic mice
TP Singh, MP Schön, K Wallbrecht, P Wolf |
Experimental Dermatology | 2012 |
|
Specific IgE toward Allergenic Molecules Is a New Prognostic Marker in Patients with Sézary Syndrome
E Scala, D Abeni, P Palazzo, M Liso, D Pomponi, G Lombardo, MC Picchio, MG Narducci, G Russo, A Mari |
International Archives of Allergy and Immunology | 2012 |
|
Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma
T Han, UM Abdel-Motal, DK Chang, J Sui, A Muvaffak, J Campbell, Q Zhu, TS Kupper, WA Marasco |
PloS one | 2012 |
|
Vascular endothelial growth factor receptor-3 (VEGFR-3) expression in mycosis fungoides
IH Pedersen, A Willerslev-Olsen, CS Kauczok, T Krejsgaard, B Lauenborg, KM Kopp, C Geisler, CB Menne, Q Zhang, MA Wasik, S Dabelsten, A Woetmann, JC Becker, N Odum |
Leukemia & Lymphoma | 2012 |
|
Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology
FC Furlan, JA Sanches |
Anais Brasileiros de Dermatologia | 2012 |
|
Mycosis Fungoides: Tumour d'emblee
R Vora, S Mubashir, P Talavia, G Anjaneyan |
Indian Dermatology Online Journal | 2012 |
|
HDAC inhibitors for the treatment of cutaneous T-cell lymphomas
S Rangwala, C Zhang, M Duvic |
Future Medicinal Chemistry | 2012 |
|
Goldman's Cecil Medicine
VP Werth |
Goldman's Cecil Medicine | 2012 |
|
Photopheresis in the treatment of cutaneous T-cell lymphoma: current status
JA Zic |
Current Opinion in Oncology | 2012 |
|
Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis: Increased CCL18 expression in patients with CTCL
T Miyagaki, M Sugaya, H Suga, H Ohmatsu, H Fujita, Y Asano, Y Tada, T Kadono, S Sato |
Journal of the European Academy of Dermatology and Venereology | 2012 |
|
Lymphoproliferative Disorders Associated With Hypereosinophilia
F Roufosse, S Garaud, L Leval |
Seminars in Hematology | 2012 |
|
Indolent CD8-positive T-cell lymphoid proliferation of the ear: a report of two cases
W Zeng, VE Nava, P Cohen, M Ozdemirli |
Journal of Cutaneous Pathology | 2012 |
|
The expression of ALK in mycosis fungoides, stage IA: Letter to the Editor
FR Abdulla, H Sarpa, D Cassarino |
Journal of Cutaneous Pathology | 2012 |
|
Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy: CCL27 chemokine in early mycosis
G Goteri, S Rupoli, A Campanati, A Zizzi, P Picardi, M Cardelli, F Giantomassi, L Canafoglia, F Marchegiani, G Mozzicafreddo, G Brandozzi, D Stramazzotti, G Ganzetti, R Lisa, O Simonetti, A Offidani, I Federici, G Filosa, P Leoni |
The British journal of dermatology | 2012 |
|
Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis: Long-term treatment of CTCL with ECP
R Knobler, M Duvic, C Querfeld, D Straus, S Horwitz, J Zain, F Foss, T Kuzel, K Campbell, L Geskin |
Photodermatology, Photoimmunology & Photomedicine | 2012 |
|
Photopheresis in the treatment of cutaneous T-cell lymphoma: current status
JA Zic |
Oncology Times | 2012 |
|
Effects of recombinant hIL-2-Luffin P1 immunotoxin combining with arotinoid ethylester on the proliferation and apoptosis of Hut-78 cells
S Liu, W He, R Wang, Z Li, J Wu, Y Zhao, X Hu |
Molecular & Cellular Toxicology | 2012 |
|
T-Cell Lymphomas
F Foss |
2012 | |
|
Cutaneous epitheliotropic T-cell lymphoma in the cat: a review of the literature and five new cases
J Fontaine, M Heimann, MJ Day |
Veterinary Dermatology | 2011 |
|
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
T Krejsgaard, N Odum, C Geisler, MA Wasik, A Woetmann |
Leukemia | 2011 |
|
Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion
A Landrigan, G Yiu, K Agarwal, PJ Utz |
Leukemia & Lymphoma | 2011 |
|
Romidepsin (Istodax®, NSC 630176, FR901228, FK228, Depsipeptide): A Natural Product Recently Approved for Cutaneous T-cell Lymphoma
KM VanderMolen, W McCulloch, CJ Pearce, NH Oberlies |
The Journal of Antibiotics | 2011 |
|
Cancer of the Skin
B Berman, M Viera, S Amini, W Valins |
Cancer of the Skin | 2011 |
|
Malignant Cutaneous T-Cell Lymphoma Cells Express IL-17 Utilizing the Jak3/Stat3 Signaling Pathway
T Krejsgaard, U Ralfkiaer, E Clasen-Linde, KW Eriksen, KL Kopp, CM Bonefeld, C Geisler, S Dabelsteen, MA Wasik, E Ralfkiaer, A Woetmann, N Odum |
Journal of Investigative Dermatology | 2011 |
|
Phototherapy of mycosis fungoides: Phototherapy of mycosis fungoides
F Trautinger |
Photodermatology, Photoimmunology & Photomedicine | 2011 |
|
Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides
R Talpur, MF Demierre, L Geskin, E Baron, S Pugliese, K Eubank, JA Zic, DR Miller, M Tharp, K Bohjanen, M Duvic |
Clinical Lymphoma Myeloma and Leukemia | 2011 |
|
Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndrome
KG Evans, AB Troxel, BJ DeNardo, CE Introcaso, AH Rook, EJ Kim |
Journal of the American Academy of Dermatology | 2011 |
|
Alemtuzumab-resistant Sézary syndrome responding to zanolimumab*: Correspondence
AB Alexandroff, V Shpadaruk, WM Bamford, DB Kennedy, R Burd, MJ Dyer |
British Journal of Haematology | 2011 |
|
Cutaneous T-Cell Lymphoma: Mycosis Fungoides/Sézary Syndrome: Part 1
S Booher, SA McCann, MC Tawa |
Journal of the Dermatology Nurses' Association | 2011 |
|
Cutaneous T-Cell Lymphoma: Mycosis Fungoides/Sézary Syndrome, Part 2
S Booher, SA McCann, MC Tawa |
Journal of the Dermatology Nurses' Association | 2011 |
|
Gene transcription analysis in lesional skin of canine epitheliotropic cutaneous lymphoma using quantitative real-time RT-PCR
N Chimura, N Kondo, S Shibata, T Kimura, T Mori, Y Hoshino, N Murayama, M Nagata, K Ide, K Nishifuji, H Kamishina, S Maeda |
Veterinary Immunology and Immunopathology | 2011 |
|
The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells: Histone deacetylase inhibitors in CTCL
CE Tiffon, JE Adams, L der Fits, S Wen, PA Townsend, A Ganesan, E Hodges, MH Vermeer, G Packham |
British Journal of Pharmacology | 2011 |
|
Narrowband Ultraviolet B Phototherapy of Early Stage Mycosis Fungoides in Korean Patients
MS Jang, JW Baek, JB Park, DY Kang, JS Kang, KS Suh, ST Kim |
Annals of Dermatology | 2011 |
|
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
EA Olsen, AH Rook, J Zic, Y Kim, P Porcu, C Querfeld, G Wood, MF Demierre, M Pittelkow, LD Wilson, L Pinter-Brown, R Advani, S Parker, EJ Kim, JM Junkins-Hopkins, F Foss, P Cacchio, M Duvic |
Journal of the American Academy of Dermatology | 2011 |
|
Experiencia de linfomas cutáneos entre enero de 1995 y abril de 2008 en el Instituto Nacional de Cancerología
X Rueda, C Cortés, Á Acosta |
Revista Colombiana de Cancerología | 2011 |
|
STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL
N Verma, A Davies, A Long, D Kelleher, Y Volkov |
Cellular & Molecular Biology Letters | 2010 |
|
Phase II Clinical Trial of Intratumoral Application of TG1042 (Adenovirus-interferon-γ) in Patients With Advanced Cutaneous T-cell Lymphomas and Multilesional Cutaneous B-cell Lymphomas
R Dummer, S Eichmüller, S Gellrich, C Assaf, B Dreno, M Schiller, O Dereure, M Baudard, M Bagot, A Khammari, P Bleuzen, V Bataille, A Derbij, N Wiedemann, T Waterboer, M Lusky, B Acres, M Urosevic-Maiwald |
Molecular Therapy | 2010 |
|
Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors
JJ Campbell, RA Clark, R Watanabe, TS Kupper |
Blood | 2010 |
|
Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma
K Yamanaka, RC Fuhlbrigge, H Mizutani, TS Kupper |
Archives of Dermatological Research | 2010 |
|
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
YH Kim, M Girardi, M Duvic, T Kuzel, BK Link, L Pinter-Brown, AH Rook |
Journal of the American Academy of Dermatology | 2010 |
|
COX-2-dependent PGE2 acts as a growth factor in mycosis fungoides (MF)
KL Kopp, CS Kauczok, B Lauenborg, T Krejsgaard, KW Eriksen, Q Zhang, MA Wasik, C Geisler, E Ralfkiaer, JC Becker, N Ødum, A Woetmann |
Leukemia | 2010 |
|
Natural Killer Cells
D Mavilio, A Hosmalin, D Scott-Algara |
Natural Killer Cells | 2010 |
|
Cell death induction and nitric oxide biosynthesis in white poplar (Populus alba) suspension cultures exposed to alfalfa saponins
A Balestrazzi, V Agoni, A Tava, P Avato, E Biazzi, E Raimondi, A Macovei, D Carbonera |
Physiologia Plantarum | 2010 |
|
Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome: Predictors of response to extracorporeal photopheresis
LY McGirt, C Thoburn, A Hess, EC Vonderheid |
Photodermatology, Photoimmunology & Photomedicine | 2010 |
|
Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance
W Shao, JD Growney, Y Feng, G O'Connor, M Pu, W Zhu, YM Yao, P Kwon, S Fawell, P Atadja |
International Journal of Cancer | 2010 |
|
Cutaneous T-cell lymphoma cells are sensitive to rapamycin: CTCL cells are sensitive to rapamycin
M Kremer, K Sliva, CD Klemke, BS Schnierle |
Experimental Dermatology | 2010 |
|
A novel xenograft model of cutaneous T-cell lymphoma: A xenograft model of CTCL
T Krejsgaard, K Kopp, E Ralfkiaer, AE Willumsgaard, KW Eriksen, T Labuda, S Rasmussen, AM Mathiesen, C Geisler, B Lauenborg, JC Becker, Q Zhang, MA Wasik, N Odum, A Woetmann |
Experimental Dermatology | 2010 |
|
Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis: PDCD10 (CCM3) PROTECTS FROM APOPTOSIS IN T-CELL LYMPHOMA
B Lauenborg, K Kopp, T Krejsgaard, KW Eriksen, C Geisler, S Dabelsteen, R Gniadecki, Q Zhang, MA Wasik, A Woetmann, N Odum |
APMIS | 2010 |
|
Dermatopathology
JM Junkins-Hopkins, PL Myskowski, KJ Busam |
Dermatopathology | 2010 |
|
Phototherapy for mycosis fungoides in a patient with coincident systemic lupus erythematosus
A Nakamura, T Dainichi, H Tomoeda, Y Moroi, K Urabe, M Furue, T Uenotsuchi |
Journal of the American Academy of Dermatology | 2010 |
|
Immune Modulators as Therapeutic Agents for Cutaneous T-Cell Lymphoma
AH Rook, B Benoit, EJ Kim, CC Vittorio, A Anshelevich, BA Raphael, CE Introcaso, JM Gardner, KG Evans, K Morrissey, S Samimi, AC Musiek, LC Showe, MA Wasik, M Wysocka |
Clinical Lymphoma Myeloma and Leukemia | 2010 |
|
Vorinostat for the treatment of cutaneous T-cell lymphoma
C Zhang, M Duvic |
Expert Review of Dermatology | 2010 |
|
Treatment of cutaneous lymphomas: today and tomorrow
D S Mestel, M Beyer, M Steinhoff, W Sterry |
Actas Dermo-Sifiliográficas | 2010 |
|
Total Skin Electron Beam and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Mycosis Fungoides and Sézary Syndrome
M Duvic, M Donato, B Dabaja, H Richmond, L Singh, W Wei, S Acholonu, I Khouri, R Champlin, C Hosing |
Journal of Clinical Oncology | 2010 |
|
Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas
T Watanabe |
Expert Opinion on Investigational Drugs | 2010 |
|
A mouse model for the Sézary syndrome
U Doebbeling |
Journal of Experimental & Clinical Cancer Research | 2010 |
|
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma
T Krejsgaard, CS Vetter-Kauczok, A Woetmann, H Kneitz, KW Eriksen, P Lovato, Q Zhang, MA Wasik, C Geisler, E Ralfkiaer, JC Becker, N Ødum |
Blood | 2009 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
|
Canine cutaneous epitheliotropic T-cell lymphoma: a review
J Fontaine, C Bovens, S Bettenay, RS Mueller |
Veterinary and Comparative Oncology | 2009 |
|
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
RL Piekarz, R Frye, M Turner, JJ Wright, SL Allen, MH Kirschbaum, J Zain, HM Prince, JP Leonard, LJ Geskin, C Reeder, D Joske, WD Figg, ER Gardner, SM Steinberg, ES Jaffe, M Stetler-Stevenson, S Lade, AT Fojo, SE Bates |
Journal of Clinical Oncology | 2009 |
|
Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors
XS Wu, AS Lonsdorf, ST Hwang |
Journal of Investigative Dermatology | 2009 |
|
How I treat mycosis fungoides and Sezary syndrome
HM Prince, S Whittaker, RT Hoppe |
Blood | 2009 |
|
IgA nephropathy associated with cutaneous T cell lymphoma
A Bajel, MY Lin, PA Hill, D Goodman, C McCormack, P Foley, J Davison, D Hönemann, M Kenealy, S Lade, G Ryan, HM Prince |
Leukemia & Lymphoma | 2009 |
|
Molecular basis of the anti-cancer effects of histone deacetylase inhibitors
MT Epping, R Bernards |
The International Journal of Biochemistry & Cell Biology | 2009 |
|
Peripheral blood flow cytometry based diagnosis in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: Implications for more extensive use
L Benetatos, L Dova, G Baxevanos, NI Kolaitis, KL Bourantas, G Vartholomatos |
Cytometry Part B Clinical Cytometry | 2009 |
|
Immunomodulatory therapy of cutaneous T-cell lymphoma: A multimodality approach in advanced disease
JM Junkins-Hopkins |
Journal of the American Academy of Dermatology | 2009 |
|
A novel regimen of vorinostat with interferon gamma for refractory Sézary syndrome
JM Gardner, CE Introcaso, SD Nasta, EJ Kim, CC Vittorio, AH Rook |
Journal of the American Academy of Dermatology | 2009 |
|
Therapy of Sézary syndrome
JS Kirby, EJ Kim, AH Rook |
Expert Review of Dermatology | 2009 |
|
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
RL Piekarz, R Frye, M Turner, JJ Wright, SL Allen, MH Kirschbaum, J Zain, HM Prince, JP Leonard, LJ Geskin, C Reeder, D Joske, WD Figg, ER Gardner, SM Steinberg, ES Jaffe, M Stetler-Stevenson, S Lade, AT Fojo, SE Bates |
Journal of Clinical Oncology | 2009 |
|
Linfoma subcutâneo de células T paniculite-símile
RS Paschoal, RN Cardilli, D Arruda, BP Simões, CS Souza |
Anais Brasileiros de Dermatologia | 2009 |
|
Fortschritte der praktischen Dermatologie und Venerologie
T Ruzicka, H Wolff, P Thomas, J Prinz |
2009 | |
|
Neuroimmunology of the Skin
RD Granstein, TA Luger |
2009 | |
|
Light-Based Therapies for Skin of Color
E Baron |
2009 | |
|
The Role of Neuropeptide Endopeptidases in Cutaneous Immunity
Scholzen TE |
2009 | |
|
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
O Khan, NB la Thangue |
Nature clinical practice. Oncology | 2008 |
|
Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma
E Capriotti, EC Vonderheid, CJ Thoburn, MA Wasik, DW Bahler, AD Hess |
Leukemia and Lymphoma | 2008 |
|
Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model
A Tun-Kyi, JZ Qin, PA Oberholzer, AA Navarini, JC Hassel, R Dummer, U Dobbeling |
Annals of Oncology | 2008 |
|
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism
J Chen, W Fiskus, K Eaton, P Fernandez, Y Wang, R Rao, P Lee, R Joshi, Y Yang, R Kolhe, R Balusu, P Chappa, K Natarajan, A Jillella, P Atadja, KN Bhalla |
Blood | 2008 |
|
FDG-PET/CT in the Evaluation of Cutaneous T-Cell Lymphoma
PH Kuo, BL McClennan, K Carlson, LD Wilson, RL Edelson, PW Heald, M Girardi |
Molecular Imaging and Biology | 2008 |
|
Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression
E Contassot, K Kerl, S Roques, R Shane, O Gaide, M Dupuis, AH Rook, LE French |
Blood | 2008 |
|
The role of NF-κB in lymphoid malignancies
G Packham |
British Journal of Haematology | 2008 |
|
Mycosis fungoides and Sézary syndrome
ST Hwang, JE Janik, ES Jaffe, WH Wilson |
The Lancet | 2008 |
|
Induction of T-Cell Responses against Cutaneous T-Cell Lymphomas Ex Vivo by Autologous Dendritic Cells Transfected with Amplified Tumor mRNA
X Ni, HM Richmond, XM Liao, WK Decker, LH Shiue, EJ Shpall, M Duvic |
Journal of Investigative Dermatology | 2008 |
|
Avicin D Selectively Induces Apoptosis and Downregulates p-STAT-3, bcl-2, and Survivin in Cutaneous T-Cell Lymphoma Cells
C Zhang, B Li, AS Gaikwad, V Haridas, Z Xu, JU Gutterman, M Duvic |
Journal of Investigative Dermatology | 2008 |
|
Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loading
X Shen, CL Berger, R Tigelaar, RL Edelson |
Immunological Investigations | 2008 |
|
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome
T Krejsgaard, LM Gjerdrum, E Ralfkiaer, B Lauenborg, KW Eriksen, AM Mathiesen, LF Bovin, R Gniadecki, C Geisler, LP Ryder, Q Zhang, MA Wasik, N Ødum, A Woetmann |
Leukemia | 2008 |
|
Cutaneous T-cell lymphoma and emerging therapies
R Fink-Puches, L Cerroni |
Drug Discovery Today: Disease Mechanisms | 2008 |
|
Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome
CE Introcaso, B Micaily, SK Richardson, JM Junkins-Hopkins, JS Yoon, EJ Kim, CC Vittorio, AH Rook |
Journal of the American Academy of Dermatology | 2008 |
|
Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101: AS101 and mycosis fungoides
GM Frei, M Kremer, KM Hanschmann, S Krause, M Albeck, B Sredni, BS Schnierle |
The British journal of dermatology | 2008 |
|
Stem cell transplantation in advanced cutaneous T-cell lymphoma
CE Introcaso, B Leber, K Greene, R Ubriani, AH Rook, EJ Kim |
Journal of the American Academy of Dermatology | 2008 |
|
Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations differing from primary lung cancer
S Hahtola, E Burghart, M Puputti, L Karenko, WM Abdel-Rahman, L Väkevä, L Jeskanen, S Virolainen, J Karvonen, K Salmenkivi, V Kinnula, H Joensuu, P Peltomäki, CA Klein, A Ranki |
Genes Chromosomes and Cancer | 2008 |
|
NKG2D Ligands Expression and NKG2D-Mediated NK Activity in Sezary Patients
N Dulphy, J Berrou, JA Campillo, M Bagot, A Bensussan, A Toubert |
Journal of Investigative Dermatology | 2008 |
|
Immune Function Abnormalities in Peripheral Blood Mononuclear Cell Cytokine Expression Differentiates Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
BF Chong, AJ Wilson, HM Gibson, MS Hafner, Y Luo, CJ Hedgcock, HK Wong |
Clinical cancer research | 2008 |
|
Cutaneous T-cell Lymphoma
F Lansigan, J Choi, FM Foss |
Hematology/Oncology Clinics of North America | 2008 |
|
Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-γ and narrowband UVB in patients with mycosis fungoides
T Shimauchi, K Sugita, D Nishio, H Isoda, S Abe, Y Yamada, R Hino, M Ogata, K Kabashima, Y Tokura |
Journal of Dermatological Science | 2008 |
|
Patch-stage mycosis fungoides in remission after therapy with alefacept
WH Green, SS Leicht, GA Youngberg |
Journal of the American Academy of Dermatology | 2008 |
|
Manifestations dermatologiques des maladies du système hématopoïétique et oncologie dermatologique
D Bessis, C Francès, B Guillot, JJ Guilhou |
2008 | |
|
Three Cases of Mycosis Fungoides Presenting with Purpura Pigmentosa Chronica
K SUGITA, R HINO, K KABASHIMA, Y TOKURA, T HAMADA, K MURATA |
Nishi Nihon Hifuka | 2008 |
|
Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
L Ellis, Y Pan, GK Smyth, DJ George, C McCormack, R Williams-Truax, M Mita, J Beck, H Burris, G Ryan, P Atadja, D Butterfoss, M Dugan, K Culver, RW Johnstone, HM Prince |
Clinical cancer research | 2008 |
|
Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome
J Shin, S Monti, DJ Aires, M Duvic, T Golub, DA Jones, TS Kupper |
Blood | 2007 |
|
Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat
M Duvic, J Vu |
Biologics : targets & therapy | 2007 |
|
Cutaneous T-cell lymphoma: Biologic targets for therapy
J Choi, F Foss |
Current Hematologic Malignancy Reports | 2007 |
|
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
M Duvic, J Vu |
Expert Opinion on Investigational Drugs | 2007 |
|
Vorinostat
S Grant, C Easley, P Kirkpatrick |
Nature Reviews Drug Discovery | 2007 |
|
Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia
T Nakayama, K Hieshima, T Arao, Z Jin, D Nagakubo, AK Shirakawa, Y Yamada, M Fujii, N Oiso, A Kawada, K Nishio, O Yoshie |
Oncogene | 2007 |
|
Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma
DJ Straus, M Duvic, T Kuzel, S Horwitz, MF Demierre, P Myskowski, S Steckel |
Cancer | 2007 |
|
Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis
CH Lee, AJ Mamelak, EC Vonderheid |
International Journal of Dermatology | 2007 |
|
How low can you go: quality effects of an anti-CD4 antibody
EJ Kim, AH Rook |
Blood | 2007 |
|
Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma
JD Miller, EB Kirkland, DS Domingo, H Scull, B Jekutis, M Dallas, KD Cooper, ED Baron |
Photodermatology, Photoimmunology & Photomedicine | 2007 |
|
Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides
ML Lokitz, HK Wong |
Photodermatology, Photoimmunology & Photomedicine | 2007 |
|
Synthetic Imidazoquinolines Potently and Broadly Activate the Cellular Immune Response of Patients with Cutaneous T-Cell Lymphoma: Synergy with Interferon-γ Enhances Production of Interleukin-12
M Wysocka, S Newton, BM Benoit, C Introcaso, AS Hancock, J Chehimi, SK Richardson, JM Gelfand, LJ Montaner, AH Rook |
Clinical Lymphoma & Myeloma | 2007 |
|
Cutaneous T-Cell Lymphoma: Overview and Nursing Perspectives
SA McCann |
Nursing Clinics of North America | 2007 |
|
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma
SJ Whittaker, FM Foss |
Cancer Treatment Reviews | 2007 |
|
Progressive multifocal leukoencephalopathy from JC virus in a patient with advanced mycosis fungoides
J Lee, SK Richardson, ER Melhem, AH Rook, EJ Kim |
Journal of the American Academy of Dermatology | 2007 |
|
Textbook of Men's Health and Aging, Second Edition
I Effendy, K Kuschela |
Textbook of Men's Health and Aging, Second Edition | 2007 |
|
Classification and Treatment of Rare and Aggressive Types of Peripheral T-Cell/Natural Killer-Cell Lymphomas of the Skin
D Rezania, L Sokol, HD Cualing |
Cancer control : journal of the Moffitt Cancer Center | 2007 |
|
Treatment of Transformed Mycosis Fungoides with Intermittent Low-Dose Gemcitabine
O Awar, M Duvic |
Oncology | 2007 |
|
Platelet-Activating Factor Is Crucial in Psoralen and Ultraviolet A-Induced Immune Suppression, Inflammation, and Apoptosis
P Wolf, DX Nghiem, JP Walterscheid, S Byrne, Y Matsumura, Y Matsumura, C Bucana, HN Ananthaswamy, SE Ullrich |
The American Journal of Pathology | 2006 |
|
Mycosis fungoides and sezary syndrome: An update
EJ Kim, J Lin, JM Hopkins, CC Vittorio, AH Rook |
Current Oncology Reports | 2006 |
|
The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines
M Baśkiewicz-Masiuk, M Walczak, R Grzegrzółka, D Rogowska, B Machaliński |
Archives of Dermatological Research | 2006 |
|
Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma
MM Tiemessen, TJ Mitchell, L Hendry, SJ Whittaker, LS Taams, S John |
Journal of Investigative Dermatology | 2006 |
|
Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas
A Ringrose, Y Zhou, E Pang, L Zhou, AE Lin, G Sheng, XJ Li, A Weng, MW Su, MR Pittelkow, X Jiang |
Leukemia | 2006 |
|
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
T Krejsgaard, CS Vetter-Kauczok, A Woetmann, P Lovato, T Labuda, KW Eriksen, Q Zhang, JC Becker, N Ødum |
Leukemia | 2006 |
|
Recombinant Measles Virus Induces Cytolysis of Cutaneous T-Cell Lymphoma In Vitro and In Vivo
V Künzi, PA Oberholzer, L Heinzerling, R Dummer, HY Naim |
Journal of Investigative Dermatology | 2006 |
|
A New Nail in the CTCL Coffin
SR Lessin |
Journal of Investigative Dermatology | 2006 |
|
Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions
SD Doherty, X Ni, CB Doherty, D Jones, X Zhao, LB Owen, M Duvic |
Archives of Dermatological Research | 2006 |
|
Clinical and laboratory experience of vorinostat (suberoylanilide hydroxamic acid) in the treatment of cutaneous T-cell lymphoma
M Duvic, C Zhang |
British Journal of Cancer | 2006 |
|
Increased Expression of CTLA-4 in Malignant T-Cells from Patients with Mycosis Fungoides – Cutaneous T Cell Lymphoma
HK Wong, AJ Wilson, HM Gibson, MS Hafner, CJ Hedgcock, CL Berger, RL Edelson, HW Lim |
Journal of Investigative Dermatology | 2006 |
|
Technology Insight: ECP for the treatment of GvHD—can we offer selective immune control without generalized immunosuppression?
SR Marshall |
Nature Clinical Practice Oncology | 2006 |
|
The Risk of Lymphoma in Patients with Psoriasis
JM Gelfand, DB Shin, AL Neimann, X Wang, DJ Margolis, AB Troxel |
Journal of Investigative Dermatology | 2006 |
|
Pathogenesis and therapy of cutaneous lymphomas ? Progress or impasse?
R Dummer, A Cozzio, M Urosevic |
Experimental Dermatology | 2006 |
|
Kutane Lymphome: Klassifikationen und stadiengerechte Therapieoptionen
R Stadler |
Der Hautarzt | 2006 |
|
Photopheresis versus transimmunization?
MD Professor |
Leukemia & Lymphoma | 2006 |
|
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
F Trautinger, R Knobler, R Willemze, K Peris, R Stadler, L Laroche, M D’Incan, A Ranki, N Pimpinelli, P Ortiz-Romero, R Dummer, T Estrach, S Whittaker |
European Journal of Cancer | 2006 |
|
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides
M Duvic, ML Sherman, GS Wood, TM Kuzel, E Olsen, F Foss, RJ Laliberté, JL Ryan, K Zonno, AH Rook |
Journal of the American Academy of Dermatology | 2006 |
|
The New World Health Organization–European Organization for Research and Treatment of Cancer Classification of Cutaneous Lymphomas
CJ Ko |
Advances in Dermatology | 2006 |
|
Processos linfoproliferativos da pele: parte 2 - linfomas cutâneos de células T e de células NK
JA Sanches, CZ de Moricz, CF Neto |
Anais Brasileiros de Dermatologia | 2006 |
|
Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
A Woetmann, P Lovato, KW Eriksen, T Krejsgaard, T Labuda, Q Zhang, AM Mathiesen, C Geisler, A Svejgaard, MA Wasik, N Ødum |
Blood | 2006 |
|
Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
A Sors, F Jean-Louis, C Pellet, L Laroche, L Dubertret, G Courtois, H Bachelez, L Michel |
Blood | 2006 |
|
Th1 Response and Cytotoxicity Genes Are Down-Regulated in Cutaneous T-Cell Lymphoma
S Hahtola, S Tuomela, L Elo, T Häkkinen, L Karenko, B Nedoszytko, H Heikkilä, U Saarialho-Kere, J Roszkiewicz, T Aittokallio, R Lahesmaa, A Ranki |
Clinical cancer research | 2006 |
|
Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action
C Zhang, V Richon, X Ni, R Talpur, M Duvic |
Journal of Investigative Dermatology | 2005 |
|
Activation of Neutrophils in Cutaneous T-Cell Lymphoma
DS Goddard, K Yamanaka, TS Kupper, DA Jones |
Clinical cancer research | 2005 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)